| 000 | 01391 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517120457.0 | ||
| 264 | 0 | _c20170426 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1365-2710 | ||
| 024 | 7 |
_a10.1111/jcpt.12459 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCuesta López, I | |
| 245 | 0 | 0 |
_aImpact of the implementation of vasoactive drug protocols on safety and efficacy in the treatment of critically ill patients. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacy and therapeutics _cDec 2016 |
||
| 300 |
_a703-710 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiovascular Agents _xadverse effects |
| 650 | 0 | 4 |
_aCritical Illness _xtherapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntensive Care Units |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMedication Errors _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSafety |
| 700 | 1 | _aSánchez Cuervo, M | |
| 700 | 1 | _aCandela Toha, Á | |
| 700 | 1 | _aBenedí González, J | |
| 700 | 1 | _aBermejo Vicedo, T | |
| 773 | 0 |
_tJournal of clinical pharmacy and therapeutics _gvol. 41 _gno. 6 _gp. 703-710 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcpt.12459 _zAvailable from publisher's website |
| 999 |
_c26481339 _d26481339 |
||